Showing results (2561-2570 of 6,778) with videos related to
Sort By:
Pageof 678
Clinical Therapeutics|September 1, 1993
Experimental use of pravastatin in patients with primary biliary cirrhosis associated with hypercholesterolemiaT Kurihara, M Akimoto, K Abe, et al.Clinical Therapeutics|September 1, 1993
Economic assessment of ketorolac versus narcotic analgesics in postoperative pain managementJ P Trotter, S P Reinhart, R M Katz, et al.Clinical Therapeutics|January 1, 1994
Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitisM Prevost, Y Turenne, D W Moote, et al.Clinical Therapeutics|January 1, 1994
Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertensionD E Hilleman, S M Mohiuddin, B D Lucas, et al.Clinical Therapeutics|May 1, 1994
Clinical experience with sotalol in the treatment of cardiac arrhythmiasH L Kirschenbaum, J M RosenbergClinical Therapeutics|May 1, 1994
Long-acting nicardipine for elderly hypertensive patients: effect on diurnal variation of blood pressureT Harada, T Imamura, K Hara, et al.Clinical Therapeutics|May 1, 1994
Impact of ondansetron and granisetron on chemotherapy-induced emesis in adults: the need for comparative pharmacoeconomic dataS Hedayati, J P Moatti, J F SeitzClinical Therapeutics|April 16, 2002
Caspofungin: an echinocandin antifungal agentElizabeth A Stone, Horatio B Fung, Harold L KirschenbaumClinical Therapeutics|April 16, 2002
Treatment patterns and associated symptom improvement during six months of care for overactive bladder: a prospective, observational studyTimothy B Boone, John W Kusek, Leroy M Nyberg, et al.Clinical Therapeutics|April 16, 2002
Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trialCherri Miner, Eileen Brown, Susan McCray, et al.Pageof 678